Home › NDC Lookup › Ingredients › Amivantamab And Hyaluronidase-Lpuj (Human Recombinant)
📦 NDC / package directory — not a drug information page

Amivantamab And Hyaluronidase-Lpuj (Human Recombinant) NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Amivantamab And Hyaluronidase-Lpuj (Human Recombinant) products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

4
Package NDCs
8
Products
8
Active listings
0
Discontinued
1
Labelers
4
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
AMIVANTAMAB 2400 mg/15mL; HYALURON... 2
AMIVANTAMAB 3520 mg/22mL; HYALURON... 2
AMIVANTAMAB 1600 mg/10mL; HYALURON... 2
AMIVANTAMAB 2240 mg/14mL; HYALURON... 2
By dosage form
INJECTION 8
Top labelers
Janssen Biotech, Inc. 8

Browse records — 8 products

Drug / product Billing NDC NADAC / unit Status
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION Janssen · NDC 57894-0515-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0515-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 3520 mg/22mL; 44000 mg/22mL INJECTION Janssen · NDC 57894-0522-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01) / 22 mL in 1 VIAL, SINGLE-DOSE 57894-0522-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 1600 mg/10mL; 20000 mg/10mL INJECTION Janssen · NDC 57894-0510-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE 57894-0510-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2240 mg/14mL; 28000 mg/14mL INJECTION Janssen · NDC 57894-0514-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE 57894-0514-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 3520 mg/22mL; 44000 mg/22mL INJECTION Janssen · NDC 57894-0522-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01) / 22 mL in 1 VIAL, SINGLE-DOSE 57894-0522-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2400 mg/15mL; 30000 mg/15mL INJECTION Janssen · NDC 57894-0515-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-515-01) / 15 mL in 1 VIAL, SINGLE-DOSE 57894-0515-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 2240 mg/14mL; 28000 mg/14mL INJECTION Janssen · NDC 57894-0514-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE 57894-0514-01 — On market View →
Rybrevant Faspro AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) 1600 mg/10mL; 20000 mg/10mL INJECTION Janssen · NDC 57894-0510-01 · J9062 · 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE 57894-0510-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.